| scholarly article | Q13442814 |
| P50 | author | Julie Barber | Q42648428 |
| P2093 | author name string | S G Thompson | |
| P2860 | cites work | Modelling in economic evaluation: an unavoidable fact of life | Q28243908 |
| Cost-utility in practice: a policy maker's guide to the state of the art. | Q33550479 | ||
| Statistical analysis in pharmacoeconomic studies. A review of current issues and standards. | Q33572336 | ||
| Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation | Q33770534 | ||
| Cost-effectiveness of induction of labour versus serial antenatal monitoring in the Canadian Multicentre Postterm Pregnancy Trial | Q34279217 | ||
| Statistical guidelines for contributors to medical journals. | Q34992408 | ||
| The Lancet's statistical review process: areas for improvement by authors | Q35258496 | ||
| Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly? | Q35861601 | ||
| Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party | Q36599584 | ||
| Health care CBA/CEA: an update on the growth and composition of the literature. | Q36764577 | ||
| Identifying relevant studies for systematic reviews | Q36888457 | ||
| Methods for Comparison of Cost Data | Q36893062 | ||
| Transfer of technology from statistical journals to the biomedical literature. Past trends and future predictions | Q38570273 | ||
| Is vaccination against hepatitis B efficient? A review of world literature | Q40745292 | ||
| Sensitivity analysis in economic evaluation: a review of published studies | Q40946924 | ||
| Evaluation of cost-effectiveness research: a survey of recent publications | Q41169528 | ||
| Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? | Q41272258 | ||
| Cost and efficacy of the substitution of ambulatory for inpatient care | Q41473128 | ||
| Economic evaluation of mental health care interventions. A review | Q41476878 | ||
| Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues | Q46686334 | ||
| Continuity of care by a midwife team versus routine care during pregnancy and birth: a randomised trial | Q47871369 | ||
| Home oxygen therapy. A comparison of 2- vs 6-month patient reevaluation | Q48824953 | ||
| Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial | Q52889717 | ||
| Generalisation from phase III clinical trials: survival, quality of life, and health economics | Q53589062 | ||
| Randomized Comparative Trial and Cost Analysis of 3-Day Antimicrobial Regimens for Treatment of Acute Cystitis in Women | Q54182716 | ||
| Reporting guidelines for economic studies | Q58618939 | ||
| From efficacy to cost-effectiveness | Q60302291 | ||
| Economic analysis in randomized control trials | Q68061972 | ||
| Economic analysis and clinical trials | Q70489034 | ||
| Observation and experiment | Q73137449 | ||
| Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet | Q74805174 | ||
| P433 | issue | 7167 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | randomized controlled trial | Q1436668 |
| P304 | page(s) | 1195-1200 | |
| P577 | publication date | 1998-10-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Analysis and interpretation of cost data in randomised controlled trials: review of published studies | |
| P478 | volume | 317 |
| Q47287895 | A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia. |
| Q34100716 | A drug cost model for injuries due to road traffic accidents. |
| Q35238137 | A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery |
| Q24814496 | A randomized controlled open trial of population-based disease and case management in a Medicare Plus Choice health maintenance organization |
| Q21134145 | Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis |
| Q78527580 | Alternatives to the hazard ratio in summarizing efficacy in time-to-event studies: an example from influenza trials |
| Q30620791 | Analysis of cost data in randomized trials: an application of the non-parametric bootstrap |
| Q90324661 | Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial |
| Q47673337 | Association of insomnia severity with well-being, quality of life and health care costs: A cross-sectional study in older adults with chronic pain (PainS65+). |
| Q35338427 | Being economical with the truth: how to make your idea appear cost effective |
| Q57550754 | Children with Complex Mental Health Problems: Needs, Costs and Predictors over One Year |
| Q33939812 | Chronic fatigue in general practice: economic evaluation of counselling versus cognitive behaviour therapy. |
| Q50773142 | Chronic pain and reduced work effectiveness: the hidden cost to Australian employers |
| Q33801820 | Clinical and cost-effectiveness of adapted cognitive behaviour therapy for non-cardiac chest pain: a multicentre, randomised controlled trial |
| Q39539640 | Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. |
| Q44091768 | Clinical and economic outcomes of pneumonia in children: a longitudinal observational study in an Italian paediatric hospital |
| Q47220067 | Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size |
| Q35848895 | Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluation |
| Q37042131 | Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial |
| Q40381891 | Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials |
| Q38609646 | Cost Offset Associated With Early Start Denver Model for Children With Autism. |
| Q37325755 | Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial |
| Q30750270 | Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods |
| Q33958937 | Cost effectiveness of continuing professional development in health care: a critical review of the evidence |
| Q50662596 | Cost function estimation: the choice of a model to apply to dementia |
| Q58863496 | Cost of home palliative care compared with conventional hospital care for patients with haematological cancers in Greece |
| Q92756383 | Cost of maternal health services in low and middle-income countries: protocol for a systematic review |
| Q34030223 | Cost savings with rapid diagnostic tests for malaria in low-transmission areas: evidence from Dar es Salaam, Tanzania |
| Q26825405 | Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report |
| Q27311227 | Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial |
| Q44196677 | Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndrome |
| Q34432229 | Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging Trial |
| Q36506909 | Cost-effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion? |
| Q47267056 | Cost-utility analysis conducted alongside randomized controlled trials: are economic end points considered in sample size calculations and does it matter? |
| Q90085124 | Cost-utility analysis of interventions to improve effectiveness of exercise therapy for adults with knee osteoarthritis: the BEEP trial |
| Q36896933 | Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial. |
| Q33304060 | Costs and consequences of treatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomised trial |
| Q33262378 | Costs of shoulder pain in primary care consulters: a prospective cohort study in The Netherlands |
| Q24791086 | Critical appraisal skills training for health care professionals: a randomized controlled trial [ISRCTN46272378] |
| Q28540737 | Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru |
| Q37016589 | Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs |
| Q49009690 | Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy |
| Q47576690 | Direct economic impact of Parkinson's disease: A research survey in the United Kingdom |
| Q51222526 | Documenting the Benefits and Cost Savings of a Large Multistate Cancer Pathway Program From a Payer's Perspective |
| Q53338986 | Donepezil use in managed Medicare: effect on health care costs and utilization |
| Q36633647 | Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial |
| Q74319880 | Economic analysis of randomized, controlled trials |
| Q33831406 | Economic burden of rheumatoid arthritis: a systematic review |
| Q45088972 | Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis |
| Q48104028 | Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial. |
| Q33572010 | Economic evaluation of nurse practitioners versus GPs in treating common conditions |
| Q34055070 | Economic evaluation within a factorial-design randomised controlled trial of exercise, manual therapy, or both interventions for osteoarthritis of the hip or knee: study protocol |
| Q36266814 | Economic evaluations: a new avenue of outcome assessment in spinal disorders |
| Q33948345 | Economics of prematurity in the era of managed care. |
| Q30565667 | Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials |
| Q36357919 | Enteral nutrition and oral nutrition supplements: a review of the economics literature |
| Q37776751 | Estimating the impact of healthcare-associated infections on length of stay and costs |
| Q30847023 | Evaluating effectiveness and cost-effectiveness of a group psychological intervention using cognitive behavioural strategies for women with common mental disorders in conflict-affected rural Pakistan: study protocol for a randomised controlled trial |
| Q53889673 | Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial |
| Q42654085 | Evaluation of the cost for laparoscopic-assisted Billroth I gastrectomy |
| Q57165336 | Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey |
| Q92942747 | Factors associated with costs and health outcomes in patients with Back and leg pain in primary care: a prospective cohort analysis |
| Q30482238 | Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial |
| Q59128429 | Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis |
| Q33930587 | Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy |
| Q39614116 | How much are we willing to pay to prevent a fall? Cost-effectiveness of a multifactorial falls prevention program for community-dwelling older adults |
| Q30593090 | How should cost data in pragmatic randomised trials be analysed? |
| Q37223305 | Impact of personality status on the outcomes and cost of cognitive-behavioural therapy for health anxiety. |
| Q41874781 | Importance of health economics must be recognised when trials are designed |
| Q37426722 | In search of the evidentiary foundation of published Canadian economic evaluations (2001-06). |
| Q34798792 | Inferences about population means of health care costs |
| Q60302260 | Joint teleconsultations (virtual outreach) versus standard outpatient appointments for patients referred by their general practitioner for a specialist opinion: a randomised trial |
| Q39428031 | Linking abuse and recovery through advocacy: an observational study. |
| Q73163919 | Maintenance of patency following remote superficial femoral artery endarterectomy |
| Q55437072 | Making free public healthcare attractive: optimizing health equity funds in Cambodia. |
| Q30801243 | Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses |
| Q30883427 | Methods to Analyse Cost Data of Patients Who Withdraw in a Clinical Trial Setting |
| Q30482105 | Open access follow up for inflammatory bowel disease. Would have been better to use t test than Mann-Whitney U test |
| Q34221146 | Patient costs in anticoagulation management: a comparison of primary and secondary care |
| Q36172194 | Patient self management of oral anticoagulation in routine care in the UK. |
| Q44190441 | Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes |
| Q37361582 | Randomised comparison of the effectiveness and costs of community and hospital based mental health services for children with behavioural disorders |
| Q37325570 | Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care |
| Q33926738 | Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness |
| Q50135107 | Randomized controlled trial and economic evaluation |
| Q38694952 | Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology |
| Q42665307 | Self-reports of health-care utilization: diary or questionnaire? |
| Q57550687 | Service and Wider Societal Costs of Very Young Children with Autism in the UK |
| Q50345356 | Service and wider societal costs of very young children with autism in the UK. |
| Q35094628 | Smoking status and health care costs in the perioperative period: a population-based study. |
| Q47550840 | The Effectiveness and Cost-Effectiveness of Web-Based and Home-Based Postnatal Psychoeducational Interventions for First-Time Mothers: Randomized Controlled Trial Protocol. |
| Q30983452 | The analysis of incomplete cost data due to dropout |
| Q33748108 | The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments |
| Q35048625 | The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial. |
| Q38574755 | The cost of developing and implementing a pathway for Congestive Heart Failure: not an inexpensive journey |
| Q51822485 | The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study. |
| Q34496154 | The costs of caring: medical costs of Alzheimer's disease and the managed care environment |
| Q37388118 | The economic effects of supporting tuberculosis-affected households in Peru |
| Q44115974 | The effect of alcohol consumption on cost of care in severe psychotic illness: a report from the UK700 study |
| Q36769539 | The effectiveness of Technology-assisted Cascade Training and Supervision of community health workers in delivering the Thinking Healthy Program for perinatal depression in a post-conflict area of Pakistan - study protocol for a randomized controlle |
| Q39142339 | The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand |
| Q41632919 | Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study. |
| Q30768819 | Use of Bayesian Markov Chain Monte Carlo methods to model cost-of-illness data |
| Q47961354 | When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care |
| Q73474834 | [The management trap in medicine. Introduction to a needed discussion] |
Search more.